search_icon 

close_icon

search_icon  

search_icon  

Logos Hygiene DE


Cornelia Lass-Flörl

Univ.Prof. Dr.med.univ.
Direktorin des Institutes für Hygiene und Medizinische Mikrobiologie
Facharzt für Hygiene und Mikrobiologie
Schwerpunkt: Mykologie und Krankenhaushygiene
Direktorin des CD-Labors für invasive Pilzinfektionen
European Excellence Center of Medical Mycology (ECMM)

Tel.: +43 (0)512 9003-70700
Fax: +43 (0)512 9003-73700
E-Mail: cornelia.lass-floerl@i-med.ac.at

 

Curriculum Vitae

1992
Dr. med univ. (M.D.), Medical School, University of Innsbruck
2000
Medical Specialisation (Facharzt) for Hygiene and Microbiology
2001 Habilitation for "Hygiene, Microbiology and Preventive Medicine"
Habilitation thesis: "Epidemiology and prevention of nosocomial aspergillosis"
2002
Associate Professor at the Institute of Hygiene and Social Medicine, Univ. Innsbruck
2009 Chair offer (1st Place) Vienna Medical University; Institute of Hygiene and Medical Microbiology
2009 Chair offer (1st Place) Innsbruck Medical University; Division of Hygiene and Medical Microbiology
2010 Head of the Institute of Hygiene and Medical Microbiology

 

Offices and career-related activities

2003- Member of the Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)
2004- Member of the Editorial Board "Mycoses"
2004-2012 Austrian Delegate of the European Confederation of Medical Mycology
2007-2012 Vice president of the Austrian Society of Medical Mycology
2007-2012 Member of the Executive Board (Secretary) of the EFISG ESCMID Fungal Infection Study Group
2007-2009 Member of the Editorial Board "Current Fungus Infection Reports"
2007- Coordinator of the ISHAM Aspergillus Working group
2008-2012 Member of the Executive Board (Treasurer) of the European Confederation of Medical Mycology
2008-2011 Head "Sektion Antimykotische Chemotherapie", Paul-Ehrlich-Gesellschaft
2009-2012 Member of the University Board, Graz Medical University
2009- Member of the Executive Board of the ÖGHMP
2010- Member of the Executive Board of the ÖGIT
2012-2016 Member of Executive Committee of the European Society of Medical Microbiology and Infectious Diseases (ESCMID)
2014- Member of the scientific advisory board "The Iceman"
2016- Chair of the Executive Board of the European Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases
2016- Chair of the ECMM Excellence Centers Subcommittee
2016 Infectious Diseases Society of America, Fellow
2017 European Confederation of Medical Mycology Academy, Fellow
2017 ESCMID, Fellow
2017 "Die meistzitierten Köpfe" im deutschsprachigen Raum, Publikationsanalyse 2011-2015: Mikrobiologie, Laborjournal 09/2017
2018 Designation of ECMM Excellence Centre
2020 List of highly cited researchers (Datenkonzern Clarivate)
2020 American Academy of Microbiology, Fellow


Research Grants:

Gilead Fund: Serumspiegel unter Amphocil

Pfizer Fund: In vitro susceptibility of Candida and Aspergillus against Voriconazole. The interaction of sertraline on Aspergillus

Austrian Science Fund: Interaction of serotonin and sertraline, 2005

MFT: Thrombocytopenia as risk factor of invasive aspergillosis, 2008-2010

MFT: Aspergillus terreus and amphotericin B resistance

Aesca Grant: Fungal infections - the role of real time PCR

MSD Grant: Study on thrombocyte adherence during interaction with Aspergillus

Unrestricted Basilea Grant: Azole resistance in fungi

MFI-IKFTZ: Platelets attack fungal mitochondriae

Gilead Fund: Antifungal Susceptibility in Aspergillus and rare molds

Pfizer Fund: Antifungal Susceptibility in Aspergillus and rare molds

EU-ECMM: IMD-cross sectional point prevanelt study

Pfizer Fund: Perspective and multicentric clinical evaluation of beta-D-glucan assay in solid organ transplant recipients using blood and BAL samples

Pfizer Fund: An Austrian experience with anidulafungin in clinical practice: A multicenter study - Part I

Pfizer Fund: An Austrian experience with anidulafungin in clinical practice: A multicenter study - Part II

Austrian Science Fund: Oxystress and human fungal pathogens: clinical and applied aspects

Austrian Science Fund: Biomarker and antifungal resistance in Aspergillus

Astellas Science Fund: Micafungin De-escalation Study

ECMM & ISHAM: Aspergillus terreus - TerrNet epidemiology worldwide

Austrian Science Fund: Host Response in Opportunistic Infections (HOROS) - doctoral programme of excellence

Christian Doppler Gesellschaft: CD laboratory for fungal infections: avoid, find and treat

H2020-MSCA-ITN: OPATHY ETN

Austrian Science Fund: Novel Biomarker in Invasive Candidiasis/Candida Sepsis